Plexus CEO Form 4: 10b5-1 sales; direct ownership 58,714

Rhea-AI Filing Summary

Plexus Corp (PLXS) President & CEO and director Todd P. Kelsey reported open‑market sales of common stock on 11/03/2025, 11/04/2025, and 11/05/2025 pursuant to a Rule 10b5‑1 plan adopted on August 16, 2024. He sold 1,500 shares at $139.12, 2,000 shares at $143.50, and 2,000 shares at $145.10. After these transactions, he beneficially owned 58,714 shares, held directly.

Insider Trade Summary

Net Seller: 5,500 shares ($785,880)

Net Sell 3 txns

Insider Kelsey Todd P.

Role President & CEO

Sold 5,500 shs ($786K)

Type	Security	Shares	Price	Value
Sale	Common Stock, $.01 par value	2,000	$145.10	$290K
Sale	Common Stock, $.01 par value	2,000	$143.50	$287K
Sale	Common Stock, $.01 par value	1,500	$139.12	$209K

Holdings After Transaction: Common Stock, $.01 par value — 58,714 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kelsey Todd P.

(Last) (First) (Middle)

ONE PLEXUS WAY

(Street)

NEENAH WI 54956

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PLEXUS CORP [ PLXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 par value	11/03/2025		S(1)		1,500	D	$139.12	62,714	D
Common Stock, $.01 par value	11/04/2025		S		2,000	D	$143.5	60,714	D
Common Stock, $.01 par value	11/05/2025		S		2,000	D	$145.1	58,714	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were sold pursuant to a Rule 10b5-1 plan adopted on August 16, 2024.

Remarks:

	/s/ Todd P. Kelsey, by Kate A. Gitter, Attorney-in-Fact	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PLXS disclose in this Form 4?

The President & CEO, Todd P. Kelsey, reported open‑market sales of Plexus common stock on 11/03/2025, 11/04/2025, and 11/05/2025.

How many PLXS shares were sold and at what prices?

1,500 shares at $139.12 on 11/03/2025; 2,000 shares at $143.50 on 11/04/2025; 2,000 shares at $145.10 on 11/05/2025.

Was a Rule 10b5-1 plan used for these PLXS transactions?

Yes. The sales were made pursuant to a Rule 10b5‑1 plan adopted on August 16, 2024.

What is Todd P. Kelsey’s role at PLXS?

He is a Director and serves as President & CEO.

How many PLXS shares does the insider own after these sales?

Following the reported transactions, he beneficially owned 58,714 shares, held directly.

Is the filing made by one reporting person or a group?

The form indicates it was filed by one reporting person.